
Professor Canan Nebigil
INSERM, University of Strasbourg, CRBS, Strasbourg (France)
Follow
Contributor content
Presentation
Targeting the PKR1 pathway and the ROS/NRF/PK2 axis for cardioprotection and biomarker discovery in anthracycline therapy
Presentation


